Fervex, powder for oral solution [lemon], 500 mg + 25 mg + 200 mg # 4
Category
Pain and fever
Scope of the drug
General
Release form
Powder
Manufacturer country
France
Package quantity, pcs
4
The main component of the drug is paracetamol, which helps to reduce fever and pain relief, and thanks to the ascorbic acid included in the composition, Fervex helps to restore the body's defenses to fight the disease.
The Fervex brand is represented by a line of juicy lemon and raspberry flavors.
And there is also a lemon-flavored, sugar-free form for use in diabetes or weight control.
Name ENG
FERVEX SS PSOL 500MG (4SACH) 4.95G RU
Clinical and pharmacological group
Drug for the symptomatic therapy of acute respiratory diseases
ATX code
N02BE51
Dosage
500 mg + 25 mg + 200 mg
Structure
Each packet contains:
active substance: paracetamol 500 mg + pheniramine 25 mg + [ascorbic acid] 200 mg.
excipients: mannitol 3.515 g
citric acid 0.050 g
povidone KZO 0.010 g
magnesium citrate 0.400 g
aspartame 0.050 g, lemon-rum flavor * 0.200 g.
* Composition of the flavoring agent: maltodextrin, acacia gum, -pinene,? -Pinene, limonene, -terpinene, linaloal, neral, -terpinene, geranial, dextrose, silicon dioxide E551, butylhydroxyanisole.
Indications
It is used for acute respiratory diseases, acute respiratory viral infections,
nasopharyngitis to relieve the following symptoms:
rhinorrhea, nasal congestion
headache
increased body temperature
lacrimation
sneezing
Storage conditions and periods
Store at temperatures between 15 and 25 ° C.
INN / Active ingredient
paracetamol + pheniramine + [ascorbic acid]
Contraindications
Hypersensitivity to paracetamol, ascorbic acid, pheniramine, or any
other component of the drug.
Erosive and ulcerative lesions of the gastrointestinal tract (in the acute phase).
Liver failure
Angle-closure glaucoma
urinary retention associated with prostate diseases and urinary disorders
Portal hypertension.
Alcoholism.
Phenylketonuria.
Deficiency of glucose-6-phosphate dehydrogenase.
Children's age (up to 15 years old).
Pregnancy and lactation (safety not studied).
Specifications
Category
Pain and fever
Scope of the drug
General
Release form
Powder
Manufacturer country
France
Package quantity, pcs
4
Minimum age from
15 years
Vacation conditions
Without recipe
Brand name
UPSA
The amount of the dosage form in the primary package
4.95 g
Primary packaging type
Sachet (sachet)
Type of consumer packaging
Pack of cardboard
Dosage form
Powder for solution for topical application
Expiration date in days
1080
The target audience
Children
Package weight, g
thirty
Mode of application
:
Inside, 1 sachet 2-3 times a day.
Before use, the contents of the sachet must be dissolved in a glass (200 ml) of warm water.
The maximum duration of treatment is 5 days.
Pharmaco-therapeutic group
:
ARI and cold" symptoms remedy (analgesic non-narcotic drug + H1-histamine receptor blocker + vitamin)
Anatomical and therapeutic characteristics
:
N02BE51 Paracetamol, in combination with other drugs (excluding psychotropic drugs)
Dosage (volume) of the substance in the preparation
:
Each packet contains: paracetamol - 0.500 g, ascorbic acid - 0.200 g, pheniramine maleate - 0.025 g.
"